Members of the global research community have joined forces in unconventional configurations to defeat the COVID-19 pandemic. And they’re working faster than ever before to find solutions.

A new clinical trial illustrates how quickly teams are assembling across industry, academia and government to meet patients’ needs. Planning for the large, Novartis-sponsored trial – which will evaluate the use of hydroxychloroquine for the treatment of …